WhaleCreep
HomeStocks › CUE

Which hedge funds own CUE? CUE BIOPHARMA INC, Q2 2026 13F holders

Open on the interactive board

12 of the hedge funds tracked by WhaleCreep disclosed a position in CUE (CUE BIOPHARMA INC) in their Q2 2026 13F filings, worth $29.1m in total. The largest holder by portfolio weight is Lion Point Capital, LP at 8.0% of its book. 12 managers opened a new position this quarter: Lion Point Capital, LP, Bleichroeder LP, Squadron Capital Management LLC, Ikarian Capital, LLC. 5 exited: Bleichroeder LP, Diadema Partners LP, Gsa Capital Partners LLP.

12tracked managers holding
12opened this quarter
5exited this quarter

Which hedge funds hold CUE? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Lion Point Capital, LPQ2 2026 8.0%$1.7m52,928 new
Bleichroeder LPQ2 2026 2.1%$11.7m370,682 new
Squadron Capital Management LLCQ2 2026 0.5%$1.6m50,000 new
Ikarian Capital, LLCQ2 2026 0.5%$3.3m104,364 new
Diadema Partners LPQ2 2026 0.5%$1.5m48,369 new
Tetragon Partners GP LTDQ2 2026 0.5%$3.0m93,819 new
Stempoint Capital LPQ2 2026 0.4%$2.1m66,995 new
Persistent Asset Partners LTDQ2 2026 0.1%$389.2k12,332 new
Adar1 Capital Management, LLCQ2 2026 0.1%$1.7m55,193 new
Seven Fleet Capital Management LPQ2 2026 0.1%$337.8k10,702 new
Boothbay Fund Management, LLCQ2 2026 0.0%$992.8k31,459 new
Citadel Advisors LLCQ2 2026 0.0%$809.0k25,633 new

Exited since the previous quarter

ManagerPrior weightPrior value
Bleichroeder LP16.6%$1.6m
Diadema Partners LP0.1%$30.3k
Gsa Capital Partners LLP0.0%$5.0k
Lion Point Capital, LP100.0%$506.4k
Persistent Asset Partners LTD0.0%$7.7k

Held in a manager's last filing on record

These managers have not filed for the latest quarter; their last disclosure is dated.

ManagerLast filingWeight
renaissanceQ2 20260.0%

How has hedge fund ownership of CUE changed?

QuarterManagers holdingCombined value
Q2 202613$29.6m
Q1 20266$2.2m
Q4 20251$72.8k
Q3 20251$163.2k
Q2 20251$91.1k
Q1 20251$33.7k
Q1 20241$518.0k
Q4 20231$230.0k
Q3 20231$138.0k
Q2 20231$566.0k
Q1 20232$628.2k
Q4 20222$760.2k
Q3 20222$1.4m
Q2 20222$1.7m
Q1 20221$2.5m
Q4 20211$1.2m

Counts every tracked manager that disclosed CUE in that quarter's filing, including managers that have since stopped filing.